Skip to search formSkip to main contentSkip to account menu

4-Aminobenzoate 500 MG Oral Capsule [Potaba]

Known as: POTABA 500 MG Oral Capsule, Potaba 0.5 GM Oral Capsule 
National Institutes of Health

Related topics

Related topics

2 relations
Oral CapsulePotaba

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Potassium-paraaminobenzoic acid (Potaba®)-associated DRESS syndrome.
1. Pileri A, Brunasso AM, Tilz H, et al. Ramipril-induced drug reaction with eosinophilia and systemic symptoms (DRESS). Eur J… 
2013
2013
Exanthema caused by ingestion of potassium p‐aminobenzoate (POTABA‐Glenwood®)
As treatment for his Peyronie’s disease (PD) a 55-yearold patient started to take 4.5 g of POTABA-Glenwood (potassium p… 
2011
2011
Peyronie’s Disease: Natural History, Diagnosis, and Medical Therapy
Peyronie’s disease (PD) is an acquired disorder of the tunica albuginea of the penis resulting in varying degrees of penile… 
2004
2004
Atteinte hépatique aiguë associée à la prise de para-aminobenzoate de potassium (Potaba®)
1989
1989
Blood levels of para-aminobenzoic acid during oral therapy
Para-aminobenzoic acid levels were measured in the blood of 13 patients suffering from either lichen sclerosus et atrophicus or… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)